An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects withPreviously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Project: Research project

Project Details

Description

An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
StatusActive
Effective start/end date10/13/2010/31/25

Funding

  • Astellas Pharma US, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.